Aurion Biotech, a biotechnology company in the clinical stage, is dedicated to developing a groundbreaking platform of advanced therapies aimed at curing blindness. Our primary focus lies in addressing corneal endothelial disease, for which we have developed one of the pioneering cell therapies that has undergone successful clinical validation. Our mission is to revolutionize corneal care through transformative treatments.

About the Aurion Biotech.

Data updated as of March 26, 2025.